Page 49 - Boxed Warning News Today

– If approved, Actemra would be the first U.S. FDA-approved immunomodulator for the treatment of COVID-19 in hospitalized patients – – Since the begin

IBSRELA®(tenapanor) is the First and Only NHE3 Inhibitor FDA Approved for the Treatment of IBS-C in AdultsFirst Novel Mechanism Therapy to Treat I...

Data from NOVA study further support the efficacy and safety of natalizumab IV when administered every six weeks as compared to the approved every four-week dosingAdditional real-world data affirm high

Data from NOVA study further support the efficacy and safety of natalizumab IV when administered every six weeks as compared to the approved every...

The FDA has approved Tlando (testosterone undecanoate), an oral testosterone replacement therapy for adult males.

Investegate announcements from Acacia Pharma Group plc, Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 2022

Ozempic® demonstrated 2.1% blood sugar reduction and also weight loss in adults with type 2 diabetes with new 2 mg dose1PLAINSBORO, N.J., March 28...

FINTEPLA® has demonstrated efficacy in the most difficult-to-treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle...

/PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a 2 mg dose of Ozempic® (semaglutide) injection, a...

The FDA has approved Fintepla (fenfluramine) oral solution for the treatment of seizures associated with LGS in patients 2 years of age and older.